Sentinel node biopsy in male breast cancer

Concetta De Cicco, Silvia M. Baio, Paolo Veronesi, Giuseppe Trifirò, Antonio Ciprian, Annarita Vento, Joel Rososchansky, Giuseppe Viale, Giovanni Paganelli

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Objective: Male breast cancer is a rare disease and axillary status is the most important prognostic indicator. Lymphoscintigraphy associated with gamma-probe guided surgery has been proved to reliably detect sentinel nodes in female patients with breast cancer. This study evaluates the feasibility of the surgical identification of sentinel node by using lymphoscintigraphy and a gamma-detecting probe in male patients, in order to select subjects who would be suitable for complete axillary lymphadenectomy. Methods: Colloid human albumin labelled with 99Tc was administered to 18 male patients with breast cancer and clinically negative axillary lymph nodes. Lymphoscintigraphy was performed the day before surgery. An intraoperative gamma-detecting probe was used to identify sentinel nodes during surgery. Results: Lymphoscintigraphy and biopsy of the sentinel node were successful in all cases. A total of 20 sentinel nodes were removed. Pathological examinations showed 11 infiltrating ductal carcinomas, two intraductal carcinomas and five intracystic papillary carcinomas. Six patients (33%) had positive sentinel node (micrometastases were found in three patients). These patients underwent axillary dissection; in five of them (83%) the sentinel node was the only positive node. Twelve patients (67%) showed negative sentinel nodes; in all of them no further surgical treatments were planned. Conclusions: As in women, lymphoscintigraphy and sentinel node biopsy under the guidance of a gamma-detecting probe proved to be an easy method for the detection of sentinel nodes in male breast carcinoma. In male patients with early stage cancer, sentinel node biopsy might represent the standard surgical procedure in order to avoid unnecessary morbidity after surgery, preserving accurate staging of the disease in the axilla.

Original languageEnglish
Pages (from-to)139-143
Number of pages5
JournalNuclear Medicine Communications
Volume25
Issue number2
DOIs
Publication statusPublished - Feb 2004

Fingerprint

Male Breast Neoplasms
Biopsy
Lymphoscintigraphy
cyhalothrin
Breast Neoplasms
Neoplasm Micrometastasis
Ductal Carcinoma
Axilla
Carcinoma, Intraductal, Noninfiltrating
Papillary Carcinoma
Colloids
Feasibility Studies
Rare Diseases
Lymph Node Excision
Ambulatory Surgical Procedures
Dissection
Albumins

Keywords

  • Breast cancer
  • Lymphoscintigraphy
  • Male
  • Sentinel node biopsy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Sentinel node biopsy in male breast cancer. / De Cicco, Concetta; Baio, Silvia M.; Veronesi, Paolo; Trifirò, Giuseppe; Ciprian, Antonio; Vento, Annarita; Rososchansky, Joel; Viale, Giuseppe; Paganelli, Giovanni.

In: Nuclear Medicine Communications, Vol. 25, No. 2, 02.2004, p. 139-143.

Research output: Contribution to journalArticle

De Cicco, Concetta ; Baio, Silvia M. ; Veronesi, Paolo ; Trifirò, Giuseppe ; Ciprian, Antonio ; Vento, Annarita ; Rososchansky, Joel ; Viale, Giuseppe ; Paganelli, Giovanni. / Sentinel node biopsy in male breast cancer. In: Nuclear Medicine Communications. 2004 ; Vol. 25, No. 2. pp. 139-143.
@article{a6545d06ec39439ebbc98b065b6909d7,
title = "Sentinel node biopsy in male breast cancer",
abstract = "Objective: Male breast cancer is a rare disease and axillary status is the most important prognostic indicator. Lymphoscintigraphy associated with gamma-probe guided surgery has been proved to reliably detect sentinel nodes in female patients with breast cancer. This study evaluates the feasibility of the surgical identification of sentinel node by using lymphoscintigraphy and a gamma-detecting probe in male patients, in order to select subjects who would be suitable for complete axillary lymphadenectomy. Methods: Colloid human albumin labelled with 99Tc was administered to 18 male patients with breast cancer and clinically negative axillary lymph nodes. Lymphoscintigraphy was performed the day before surgery. An intraoperative gamma-detecting probe was used to identify sentinel nodes during surgery. Results: Lymphoscintigraphy and biopsy of the sentinel node were successful in all cases. A total of 20 sentinel nodes were removed. Pathological examinations showed 11 infiltrating ductal carcinomas, two intraductal carcinomas and five intracystic papillary carcinomas. Six patients (33{\%}) had positive sentinel node (micrometastases were found in three patients). These patients underwent axillary dissection; in five of them (83{\%}) the sentinel node was the only positive node. Twelve patients (67{\%}) showed negative sentinel nodes; in all of them no further surgical treatments were planned. Conclusions: As in women, lymphoscintigraphy and sentinel node biopsy under the guidance of a gamma-detecting probe proved to be an easy method for the detection of sentinel nodes in male breast carcinoma. In male patients with early stage cancer, sentinel node biopsy might represent the standard surgical procedure in order to avoid unnecessary morbidity after surgery, preserving accurate staging of the disease in the axilla.",
keywords = "Breast cancer, Lymphoscintigraphy, Male, Sentinel node biopsy",
author = "{De Cicco}, Concetta and Baio, {Silvia M.} and Paolo Veronesi and Giuseppe Trifir{\`o} and Antonio Ciprian and Annarita Vento and Joel Rososchansky and Giuseppe Viale and Giovanni Paganelli",
year = "2004",
month = "2",
doi = "10.1097/00006231-200402000-00008",
language = "English",
volume = "25",
pages = "139--143",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Sentinel node biopsy in male breast cancer

AU - De Cicco, Concetta

AU - Baio, Silvia M.

AU - Veronesi, Paolo

AU - Trifirò, Giuseppe

AU - Ciprian, Antonio

AU - Vento, Annarita

AU - Rososchansky, Joel

AU - Viale, Giuseppe

AU - Paganelli, Giovanni

PY - 2004/2

Y1 - 2004/2

N2 - Objective: Male breast cancer is a rare disease and axillary status is the most important prognostic indicator. Lymphoscintigraphy associated with gamma-probe guided surgery has been proved to reliably detect sentinel nodes in female patients with breast cancer. This study evaluates the feasibility of the surgical identification of sentinel node by using lymphoscintigraphy and a gamma-detecting probe in male patients, in order to select subjects who would be suitable for complete axillary lymphadenectomy. Methods: Colloid human albumin labelled with 99Tc was administered to 18 male patients with breast cancer and clinically negative axillary lymph nodes. Lymphoscintigraphy was performed the day before surgery. An intraoperative gamma-detecting probe was used to identify sentinel nodes during surgery. Results: Lymphoscintigraphy and biopsy of the sentinel node were successful in all cases. A total of 20 sentinel nodes were removed. Pathological examinations showed 11 infiltrating ductal carcinomas, two intraductal carcinomas and five intracystic papillary carcinomas. Six patients (33%) had positive sentinel node (micrometastases were found in three patients). These patients underwent axillary dissection; in five of them (83%) the sentinel node was the only positive node. Twelve patients (67%) showed negative sentinel nodes; in all of them no further surgical treatments were planned. Conclusions: As in women, lymphoscintigraphy and sentinel node biopsy under the guidance of a gamma-detecting probe proved to be an easy method for the detection of sentinel nodes in male breast carcinoma. In male patients with early stage cancer, sentinel node biopsy might represent the standard surgical procedure in order to avoid unnecessary morbidity after surgery, preserving accurate staging of the disease in the axilla.

AB - Objective: Male breast cancer is a rare disease and axillary status is the most important prognostic indicator. Lymphoscintigraphy associated with gamma-probe guided surgery has been proved to reliably detect sentinel nodes in female patients with breast cancer. This study evaluates the feasibility of the surgical identification of sentinel node by using lymphoscintigraphy and a gamma-detecting probe in male patients, in order to select subjects who would be suitable for complete axillary lymphadenectomy. Methods: Colloid human albumin labelled with 99Tc was administered to 18 male patients with breast cancer and clinically negative axillary lymph nodes. Lymphoscintigraphy was performed the day before surgery. An intraoperative gamma-detecting probe was used to identify sentinel nodes during surgery. Results: Lymphoscintigraphy and biopsy of the sentinel node were successful in all cases. A total of 20 sentinel nodes were removed. Pathological examinations showed 11 infiltrating ductal carcinomas, two intraductal carcinomas and five intracystic papillary carcinomas. Six patients (33%) had positive sentinel node (micrometastases were found in three patients). These patients underwent axillary dissection; in five of them (83%) the sentinel node was the only positive node. Twelve patients (67%) showed negative sentinel nodes; in all of them no further surgical treatments were planned. Conclusions: As in women, lymphoscintigraphy and sentinel node biopsy under the guidance of a gamma-detecting probe proved to be an easy method for the detection of sentinel nodes in male breast carcinoma. In male patients with early stage cancer, sentinel node biopsy might represent the standard surgical procedure in order to avoid unnecessary morbidity after surgery, preserving accurate staging of the disease in the axilla.

KW - Breast cancer

KW - Lymphoscintigraphy

KW - Male

KW - Sentinel node biopsy

UR - http://www.scopus.com/inward/record.url?scp=1542345004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542345004&partnerID=8YFLogxK

U2 - 10.1097/00006231-200402000-00008

DO - 10.1097/00006231-200402000-00008

M3 - Article

C2 - 15154702

AN - SCOPUS:1542345004

VL - 25

SP - 139

EP - 143

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 2

ER -